Harald Holte - Concepedia

Author

Harald Holte

Oslo University Hospital ORCID

Also Known As

H Holte, H. HOLTE, H. Holte, HARALD HOLTE, Harald Holte, Holte H., Holte, H, Holte, Harald, K. Smeland

440

Publications

27.6K

Citations

H-Index

136

Concepts

All Affiliations

Oslo University Hospital University of Oslo Norwegian Cancer Society Helsinki University Hospital Karolinska Institutet

About

Harald Holte is an author at Oslo University Hospital specializing in medicine, immunology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	70	6K
2	Health Sciences	13	14	906
3	Natural Sciences	2	2	45
4	Education	1	1	19
5	Engineering	1	1	13

Harald Holte

188

Publications

26.8K

Citations

H-Index

Page 1

	Year	Citations
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma Stephen J. Schuster, Michael Bishop, Constantine S. Tam, New England Journal of Medicine	2018	3.9K
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma Andreas Rosenwald, George W. Wright, Wing C. Chan, New England Journal of Medicine	2002	3.8K
Stromal Gene Signatures in Large-B-Cell Lymphomas Georg Lenz, George W. Wright, Sandeep S. Davé, New England Journal of Medicine	2008	1.8K
A Prognostic Score for Advanced Hodgkin's Disease Dirk Hasenclever, Volker Diehl, Jamés O. Armitage, New England Journal of Medicine	1998	1.7K
Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells Sandeep S. Davé, George W. Wright, Bruce K. Tan, New England Journal of Medicine	2004	1.4K
Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma Andreas Rosenwald, George W. Wright, Karen Leroy, The Journal of Experimental Medicine Molecular DiagnosisImmunologyPathologyImmunotherapyHematological Malignancy	2003	1.1K
The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma Andreas Rosenwald, George W. Wright, Adrian Wiestner, Cancer Cell Lymphoid NeoplasiaMantle Cell LymphomaOncogenic AgentQuantitative IntegratorPathology	2003	924
Molecular Diagnosis of Burkitt's Lymphoma Sandeep S. Davé, Kai Fu, George W. Wright, New England Journal of Medicine	2006	902
Rituximab maintenance improves clinical outcome of relapsed/resistant follicular non-Hodgkin lymphoma in patients both with and without rituximab during induction: results of a prospective randomized phase 3 intergroup trial Marinus H. J. van Oers, Richard Klasa, Robert Marcus, Blood	2006	592
Up-Front Autologous Stem-Cell Transplantation in Peripheral T-Cell Lymphoma: NLG-T-01 Francesco d’Amore, Thomas Relander, Grete F. Lauritzsen, Journal of Clinical Oncology	2012	584

Page 1